Literature DB >> 4050289

A study of the influence of ovulation stimulants and oral contraception on twin births in England.

F Webster, J M Elwood.   

Abstract

A study of 111 mothers of twins in Nottinghamshire, England, in 1981-82 showed that at least 12 had used ovulation stimulants, compared to 2 of 102 mothers of singletons. Thus, the use of ovulation stimulants increased the twinning rate of this population by about 10 percent; this may explain the recently noted levelling off in the secular decline in twinning rates. In contrast to a recent study in France, no association between twinning and prior use of oral contraceptives was seen.

Keywords:  Contraception; Contraceptive Methods--side effects; Developed Countries; England; Europe; Family Planning; Genetics; Genetics, Population; Northern Europe; Oral Contraceptives--side effects; Ovulation; Pregnancy; Pregnancy, Multiple; Reproduction; United Kingdom

Mesh:

Substances:

Year:  1985        PMID: 4050289     DOI: 10.1017/s0001566000004992

Source DB:  PubMed          Journal:  Acta Genet Med Gemellol (Roma)        ISSN: 0001-5660


  4 in total

1.  Twin peaks, extramarital conceptions, and virgin births: is there a connection?

Authors:  M Murphy; V Seagroatt
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

2.  Is there an increased risk of twinning after discontinuation of the oral contraceptive pill?

Authors:  M F Murphy; M J Campbell; M Bone
Journal:  J Epidemiol Community Health       Date:  1989-09       Impact factor: 3.710

3.  Research in epidemiology and community health in the medical curriculum: students' opinions of the Nottingham experience.

Authors:  J M Elwood; J C Pearson; R J Madeley; R F Logan; M W Beaver; P A Gillies; J Little; A Langham
Journal:  J Epidemiol Community Health       Date:  1986-09       Impact factor: 3.710

4.  Recent trends in the incidence of multiple births and associated mortality.

Authors:  B J Botting; I M Davies; A J Macfarlane
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.